Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, March 22 '25)

Image
By G.M.

 


    Ann Intern Med


  1. Correction: Anticoagulation Among Patients Hospitalized for COVID-19.
    Ann Intern Med. 2025 Mar 18. doi: 10.7326/ANNALS-25-00916.
    PubMed        


    Antiviral Res

  2. SAFIRIYU AA, Hussain A, Dewangan N, Kasle G, et al
    The fusion peptide of the spike protein S2 domain may be a mimetic analog of beta-coronaviruses and serve as a novel virus-host membrane fusion inhibitor.
    Antiviral Res. 2025 Mar 16:106144. doi: 10.1016/j.antiviral.2025.106144.
    PubMed         Abstract available

  3. XU M, Zhang Z, Sun Y, Mai H, et al
    Corrigendum to "IgA class switching enhances neutralizing potency against SARS-CoV-2 by increased antibody hinge flexibility" [Antiv. Res. (2025) 106082].
    Antiviral Res. 2025 Mar 20:106146. doi: 10.1016/j.antiviral.2025.106146.
    PubMed        


    Graefes Arch Clin Exp Ophthalmol

  4. ZUREIK A, Couturier A, Delcourt C
    Evolution of ophthalmological care in adult with diabetes in France between 2010 and 2022: a nationwide study.
    Graefes Arch Clin Exp Ophthalmol. 2025 Mar 17. doi: 10.1007/s00417-025-06793.
    PubMed         Abstract available


    Int J Infect Dis

  5. LASTRUCCI V, Pacifici M, Puglia M, Alderotti G, et al
    Recent trends in hospitalizations for Respiratory Syncytial Virus after the COVID-19 pandemic and before routine immunization: seasonality and severity updates from the 2023/2024 season in Tuscany, Italy.
    Int J Infect Dis. 2025 Mar 13:107879. doi: 10.1016/j.ijid.2025.107879.
    PubMed         Abstract available


    Intensive Care Med

  6. CHEN B, Li S
    Optimizing non-intubated respiratory support in COVID-19: evaluating the impact of bundle of care strategy on awake prone positioning tolerance.
    Intensive Care Med. 2025 Mar 17. doi: 10.1007/s00134-025-07860.
    PubMed        


    Invest Radiol

  7. SONG J, Hwang EJ, Yoon SH, Park CM, et al
    Emerging Trends and Innovations in Radiologic Diagnosis of Thoracic Diseases.
    Invest Radiol. 2025 Mar 20. doi: 10.1097/RLI.0000000000001179.
    PubMed         Abstract available


    J Infect

  8. PEREZ CM, Ruiz-Rius S, Ramirez-Morros A, Vidal M, et al
    Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infections.
    J Infect. 2025 Mar 18:106473. doi: 10.1016/j.jinf.2025.106473.
    PubMed         Abstract available


    J Med Virol

  9. BOTELLO-MARABOTTO M, Tarraso J, Mulet A, Presa-Fernandez L, et al
    Metabolomic Biomarkers of Pulmonary Fibrosis in COVID-19 Patients One Year After Hospital Discharge.
    J Med Virol. 2025;97:e70289.
    PubMed         Abstract available

  10. VENTUROLI S, Bertoldi A, Manaresi E, Lazzarotto T, et al
    Epidemiology of Parvovirus B19 Infection In an Italian Metropolitan Area, 2012-2024: COVID-19 Pre-Pandemic, Pandemic and Post-Pandemic Trends.
    J Med Virol. 2025;97:e70296.
    PubMed         Abstract available

  11. FOURGEAUD J, Turlure P, Dupont M, Veyrenche N, et al
    Remdesivir for the Treatment of Human Coronavirus OC43 Encephalitis.
    J Med Virol. 2025;97:e70314.
    PubMed         Abstract available

  12. AMEGASHIE EA, Kwayisi-Darkwah CK, Adusei-Poku M, Sikeola RO, et al
    Lipid Peroxidation and Glutathione Levels Among People Living With HIV Co-infected With Human Coronaviruses in Ghana.
    J Med Virol. 2025;97:e70301.
    PubMed         Abstract available


    J Virol

  13. ZHONG Q, Qi J, Su N, Li Z, et al
    In vivo investigation of PEDV transmission via nasal infection: mechanisms of CD4(+) T-cell-mediated intestinal infection.
    J Virol. 2025 Mar 17:e0176124. doi: 10.1128/jvi.01761.
    PubMed         Abstract available

  14. SIMS A, Weir DJ, Cole SJ, Hutchinson E, et al
    SARS-CoV-2 cellular coinfection is limited by superinfection exclusion.
    J Virol. 2025 Mar 21:e0207724. doi: 10.1128/jvi.02077.
    PubMed         Abstract available

  15. BEAVIS AC, Li Z, Briggs K, Gingerich MC, et al
    Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants.
    J Virol. 2025 Mar 21:e0198924. doi: 10.1128/jvi.01989.
    PubMed         Abstract available

  16. BEAVIS AC, Xiao P, Gingerich MC, Briggs K, et al
    A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primates.
    J Virol. 2025 Mar 21:e0199024. doi: 10.1128/jvi.01990.
    PubMed         Abstract available


    Lancet Infect Dis

  17. RAMOS B, Vadlamudi NK, Han C, Sadarangani M, et al
    Future immunisation strategies to prevent Streptococcus pneumoniae infections in children and adults.
    Lancet Infect Dis. 2025 Mar 17:S1473-3099(24)00740.
    PubMed         Abstract available

  18. HASLAM E
    Lessons from the COVID-19 pandemic.
    Lancet Infect Dis. 2025 Mar 13:S1473-3099(25)00177.
    PubMed        


    Nature

  19. MERKENSCHLAGER J, Pyo AGT, Silva Santos GS, Schaefer-Babajew D, et al
    Regulated somatic hypermutation enhances antibody affinity maturation.
    Nature. 2025 Mar 19. doi: 10.1038/s41586-025-08728.
    PubMed         Abstract available


    Travel Med Infect Dis

  20. RODRIGUEZ-MORALES AJ, Puerta-Arias MC, Husni R, Montenegro-Idrogo JJ, et al
    Infectious Diseases Prevention and Vaccination in migrants in Latin America: The challenges of transit through the treacherous Darien Gap, Panama.
    Travel Med Infect Dis. 2025 Mar 18:102839. doi: 10.1016/j.tmaid.2025.102839.
    PubMed        

  21. SRIVASTAVA S, Sharma D, Sridhar SB, Kumar S, et al
    HKU5-CoV-2: A silent threat looming in bats.
    Travel Med Infect Dis. 2025;65:102838.
    PubMed        

Labels

Labels:

Comments

Post a Comment

Popular posts from this blog

#USA, APHIS Confirms {Avian #Influenza #H5N1} #D11 #Genotype in Dairy #Cattle in #Nevada

By G.M.
On January 31, 2025, the USDA Animal and Plant Health Inspection Service (APHIS) National Veterinary Services Laboratories (NVSL) confirmed by whole genome sequence the first detection of highly pathogenic avian influenza (HPAI) H5N1 clade 2.3.4.4b, genotype D1.1 in dairy cattle .  This confirmation was a result of State tracing and investigation, following an initial detection on silo testing under the USDA’s National Milk Testing Strategy (NMTS) in Nevada.  USDA APHIS continues to work with the Nevada Department of Agriculture by conducting additional on-farm investigation, testing, and gathering additional epidemiological information to better understand this detection and limit further disease spread.  This is the first detection of this virus genotype in dairy cattle (all previous detections in dairy cattle have been HPAI H5N1 clade 2.3.4.4b, genotype B3.13 ).  Genotype D1.1 represents the predominant genotype in the North American flyways this past fall an...
Post a Comment
Read more »

#USA, After #Birdflu Detected in Local #Cat, County #Health Officials Say #Pet Owners Should Contact Veterinarian When Their Pets are Sick

By G.M.
Redwood City — State veterinary and health officials have confirmed a case of H5N1 (bird flu) in a domestic stray cat in San Mateo County.  The infection, which is not related to the recent instance of bird flu in a backyard flock , was found in a stray cat in Half Moon Bay that had been taken in by a family .  When it showed symptoms, they took it to Peninsula Humane Society, whose veterinarians examined it and requested testing. Lab results confirmed H5N1.  It is not known how the cat was infected and it was euthanized due to its condition. Cats may be exposed to bird flu by consuming infected bird , being in environments contaminated with the virus and consuming unpasteurized milk from infected cows or raw food. Inside domestic animals, such as cats and dogs, that go outside are also at risk of infection.​​​​​​​ According to the Centers for Disease Control and Prevention, the risk of cats spreading H5N1 to people is extremely low, though it is possible for cats to spre...
Post a Comment
Read more »

#USA, Novel #Influenza A #H5N1 Virus: One Pediatric Case in #California {FluView}

By G.M.
 {Excerpt} One confirmed human infection with influenza A(H5) virus was reported to CDC this week. To date, human-to-human transmission of influenza A(H5) virus has not been identified in the United States. This case was reported by the California Department of Public Health and occurred in a child less than 18 years old with no known contact with influenza A(H5N1) virus-infected animals or humans . The investigation into the source of infection for this case is ongoing , and no human-to-human transmission has been identified. A specimen from the individual was tested at a public health laboratory using the CDC influenza A(H5) assay before being sent to CDC for further testing. The specimen was positive for influenza A(H5) virus using diagnostic RT-PCR at CDC. Additional analysis including genetic sequencing is underway. In response to this detection, additional case investigation and contact monitoring are being conducted by public health officials in California. There have now be...
Post a Comment
Read more »